Catalent, Inc. Stock

Equities

CTLT

US1488061029

Pharmaceuticals

Market Closed - Nyse 16:00:02 2024-06-18 EDT 5-day change 1st Jan Change
55.07 USD -0.25% Intraday chart for Catalent, Inc. -1.33% +22.57%
Sales 2024 * 4.34B 5.96B Sales 2025 * 4.59B 6.3B Capitalization 9.97B 13.67B
Net income 2024 * -853M -1.17B Net income 2025 * 35M 48.02M EV / Sales 2024 * 3.38 x
Net Debt 2024 * 4.73B 6.49B Net Debt 2025 * 4.69B 6.43B EV / Sales 2025 * 3.19 x
P/E ratio 2024 *
-11.2 x
P/E ratio 2025 *
795 x
Employees 17,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.83%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Catalent, Inc.

1 day-0.25%
1 week-1.33%
Current month+2.38%
1 month-0.54%
3 months-1.59%
6 months+31.46%
Current year+22.57%
More quotes
1 week
55.03
Extreme 55.03
56.10
1 month
53.51
Extreme 53.51
56.54
Current year
42.11
Extreme 42.11
60.20
1 year
31.80
Extreme 31.8001
60.20
3 years
31.45
Extreme 31.45
142.64
5 years
31.04
Extreme 31.04
142.64
10 years
18.92
Extreme 18.92
142.64
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 10-09-30
Director of Finance/CFO 52 23-07-04
Chief Tech/Sci/R&D Officer - 16-12-31
Members of the board TitleAgeSince
Director/Board Member 79 14-07-31
Chairman 69 18-02-15
Director/Board Member 74 15-07-27
More insiders
Date Price Change Volume
24-06-18 55.07 -0.25% 986,393
24-06-17 55.21 -0.49% 1,559,130
24-06-14 55.48 -0.88% 1,522,347
24-06-13 55.97 +0.04% 758,168
24-06-12 55.95 +0.25% 796,239

Delayed Quote Nyse, June 18, 2024 at 04:00 pm

More quotes
Catalent, Inc. is specialized in pharmaceutical outsourcing services. The group offers solutions for the development and formulation of drugs, biological products and animal health products. Net sales break down by activity as follows: - provision of development services and clinical supply services (55.4%); - subcontracted manufacturing services (44.6%). Net sales are distributed geographically as follows: the United States (63.2%), Europe (28.7%) and other (8.1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
55.07 USD
Average target price
63.5 USD
Spread / Average Target
+15.31%
Consensus